Madhavi Latha Somaraju

Dr. Madhavi Latha Somaraju (Chalasani) has a wealth of experience in the scientific field. Dr. Madhavi Latha began their career in 2001 as a Management Trainee at Shasun, where they were responsible for cloning and amplifying recombinant erythropoietin producing bacteriophage. In 2003, they began their Ph.D at L.V. Prasad Eye Institute, where they studied the function of the glaucoma-associated protein optineurin and its mutants. Dr. Madhavi Latha was also a Project Assistant at the same institute. In 2008, they moved to Centre for Cellular and Molecular Biology as a Research Associate. Here, they independently lead a project and demonstrated retinal cell-specific disease pathogenic mechanism of glaucoma causing E50K mutant of optineurin. In 2010, they were a Postdoctoral Fellow at L.V. Prasad Eye Institute and a Project Investigator at Centre for Cellular and Molecular Biology. From 2015 to 2018, Dr. Somaraju was a Postdoctoral Research Fellow at Nanyang Technological University, Singapore, where they discovered a novel molecular mechanism by which CG-NAP, an adaptor protein, mediates T-lymphocyte migration. Currently, they are a Scientist II at Mnemo Therapeutics, where they are focused on understanding the role of CCR2+ cells in regulating vascular integrity and skin integrity in bleomycin-induced skin fibrosis model.

Dr. Madhavi Latha Somaraju (Chalasani) obtained their Doctor of Philosophy (Ph.D.) in Studies on the function of the glaucoma-associated protein optineurin and its mutants from the L.V.Prasad Eye Institute, Centre for Cellular and Molecular Biology/ University of Hyderabad between 2003 and 2008. Dr. Madhavi Latha then received their M.Sc in Bio-technology from Banasthali Vidyapith between 1999 and 2001. Finally, they obtained their B.Sc in Biotechnology from T.S.R and T.B.K. College between 1996 and 1999.